Please Wait
Applying Filters...
menu
    • menu
    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-23

    Virtual Booth

    An Enquiry

    Menu

    Lactose Monohydrate

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER

    02 1DALVANCE

    03 1MICAFUNGIN SODIUM

    04 8OXALIPLATIN

    05 1VARUBI

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    ABBVIE
    U.S.A
    arrow
    ACS GCI
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DALBAVANCIN HYDROCHLORIDE

    Drug : DALVANCE

    Dosage Form : POWDER; INTRAVENOUS

    Application Number : 21883

    Country : US

    Patented : Yes

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ACTAVIS

    OXALIPLATIN

    arrow
    ACS GCI
    Not Confirmed
    ACTAVIS
    Ireland
    arrow
    ACS GCI
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    OXALIPLATIN

    Drug : OXALIPLATIN

    Dosage Form : INJECTABLE; INTRAVENOUS

    Application Number : 204880

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    ACTAVIS TOTOWA

    OXALIPLATIN

    arrow
    ACS GCI
    Not Confirmed
    ACTAVIS TOTOWA
    Ireland
    arrow
    ACS GCI
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    OXALIPLATIN

    Drug : OXALIPLATIN

    Dosage Form : INJECTABLE; INTRAVENOUS

    Application Number : 78803

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    BAYER HLTHCARE

    MOXIFLOXACIN HYDROCHLORIDE

    arrow
    ACS GCI
    Not Confirmed
    BAYER HLTHCARE
    Germany
    arrow
    ACS GCI
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MOXIFLOXACIN HYDROCHLORIDE

    Drug : AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER

    Dosage Form : SOLUTION; INTRAVENOUS

    Application Number : 21277

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    FRESENIUS KABI ONCOL

    OXALIPLATIN

    arrow
    ACS GCI
    Not Confirmed
    FRESENIUS KABI ONCOL
    Sweden
    arrow
    ACS GCI
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    OXALIPLATIN

    Drug : OXALIPLATIN

    Dosage Form : INJECTABLE; INTRAVENOUS

    Application Number : 78810

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    HIKMA

    MICAFUNGIN SODIUM

    arrow
    ACS GCI
    Not Confirmed
    HIKMA
    United Kingdom
    arrow
    ACS GCI
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MICAFUNGIN SODIUM

    Drug : MICAFUNGIN SODIUM

    Dosage Form : INJECTABLE; INTRAVENOUS

    Application Number : 213261

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    HOSPIRA INC

    OXALIPLATIN

    arrow
    ACS GCI
    Not Confirmed
    HOSPIRA INC
    U.S.A
    arrow
    ACS GCI
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    OXALIPLATIN

    Drug : OXALIPLATIN

    Dosage Form : INJECTABLE; INTRAVENOUS

    Application Number : 78815

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    QILU PHARM HAINAN

    OXALIPLATIN

    arrow
    ACS GCI
    Not Confirmed
    QILU PHARM HAINAN
    China
    arrow
    ACS GCI
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    OXALIPLATIN

    Drug : OXALIPLATIN

    Dosage Form : INJECTABLE; INTRAVENOUS

    Application Number : 204616

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    SUN PHARM

    OXALIPLATIN

    arrow
    ACS GCI
    Not Confirmed
    SUN PHARM
    India
    arrow
    ACS GCI
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    OXALIPLATIN

    Drug : OXALIPLATIN

    Dosage Form : INJECTABLE; INTRAVENOUS

    Application Number : 78818

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    TEVA PHARMS

    OXALIPLATIN

    arrow
    ACS GCI
    Not Confirmed
    TEVA PHARMS
    Israel
    arrow
    ACS GCI
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    OXALIPLATIN

    Drug : OXALIPLATIN

    Dosage Form : INJECTABLE; INTRAVENOUS

    Application Number : 22160

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF